Furthermore, hepatic steatosis (independent of adiposity), is associated with impaired insulin action within the liver, but also within the periphery (including adipose tissue and skeletal muscle), in both lean and non-diabetic obese people [13,25]. This evidence concerns the gene INS and fatty liver disease.